Access this stock data via API
Subscribe
Innovent Biologics Inc.
0
0
0%

Statistics

Valuation metrics
Market cap
160.86B
Enterprise value
142.40B
Trailing P/E (ttm)
110.47
Forward P/E
42.21
PEG ratio
42.21
Price/Sales (ttm)
12.32
Price/Book (mrq)
8.50
Enterprise Value/Revenue
11.30
Enterprise Value/EBITDA
99.06
Overview
Shares outstanding
1.65B
Float
1.54B
Shares short
% Held by insiders
6.45%
% Held by institutions
52.88%
Average volume (10 days)
17.32M
Average volume (90 days)
12.91M
Price summary
52-Week low
28.65
52-Week high
109.10
52-Week change
54.80
Beta
0.46
50-Day moving average
89.37
200-Day moving average
76.40
Financials
Fiscal year
Fiscal year ends
Dec 31, 2024
Most recent quarter (mrq)
Jun 30, 2025
Profitability
Profit margin
9.91%
Operating margin
12.99%
Operational effectiveness
Return on assets
2.65%
Return on equity
8.44%
Income statement
Revenue (ttm)
12.61B
Revenue per share (ttm)
6.98
Quarterly revenue growth (yoy)
50.60%
Gross profit (ttm)
9.66B
EBITDA
278.98M
Net income to common (ttm)
1.25B
Diluted EPS (ttm)
0.74
Quarterly earnings growth (yoy)
Balance sheet
Total cash (mrq)
10.53B
Total cash per share (mrq)
5.77
Total debt (mrq)
3.73B
Total Debt/Equity (mrq)
23.43
Current ratio (mrq)
261.20%
Book value per share (mrq)
9.62
Cash flow
Cash flow statement
2.00B
Levered free cash flow (LFCF)
98.65M
Access /statistics data via our API — starting from the Pro plan.
Market closed

Exchange is currently closed
Pre-market opens in 10 hours 54 minutes

22:05
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
09:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 16:10
All times are displayed in the Asia/Hong_Kong timezone (HKT, UTC+08:00).